Recruiting at 2 sites No phase Parkinson Disease

Clinical trial for Parkinson Disease

Official title Exercise to Improve Sleep in Parkinson's Disease

ClinicalTrials.gov ID: NCT05644327

What this study is testing

What it's testing
The study wants to find out whether cardio, resistance, or combined exercise can improve sleep quality and overall quality of life for people with Parkinson's disease.
Who it's for
Adults who have Parkinson's disease and can safely take part in an exercise program.
What's involved
Participants will be assigned to cardio, resistance, combined exercise, or a waiting‑list control group and will exercise three times a week for 12 weeks. Sleep and quality‑of‑life measurements will be taken before, after, and 8 weeks later.
Time commitment
The study lasts about 20 weeks total, with 12 weeks of exercise sessions three times per week and three assessment visits.
  • This is a blinded study.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 40 and older

You may be able to join if

  • Persons with mild-moderate idiopathic Parkinson's Disease (Modified Hoehn \& Yahr Scale stages 0.5-3.5);
  • On a stable dosage of medication during the previous month;
  • Having poor sleep quality defined as a score \> 15 in the PDSS-2 and/or reporting subjective sleep complaints affecting their sleep quality;

You likely can't join if

  • Having atypical parkinsonism, dementia, stroke, or any other neurological condition;
  • Presenting severe untreated obstructive sleep apnea (OSA);
  • Having a Montreal Cognitive Assessment (MoCA) score \<18
  • Having a Beck Depression Inventory score \>31;
  • Having absolute contraindications to exercise;
  • Having severe osteoporosis;
See the full eligibility criteria
Who can join
  • Persons with mild-moderate idiopathic Parkinson's Disease (Modified Hoehn \& Yahr Scale stages 0.5-3.5);
  • On a stable dosage of medication during the previous month;
  • Having poor sleep quality defined as a score \> 15 in the PDSS-2 and/or reporting subjective sleep complaints affecting their sleep quality;
What rules you out
  • Having atypical parkinsonism, dementia, stroke, or any other neurological condition;
  • Presenting severe untreated obstructive sleep apnea (OSA);
  • Having a Montreal Cognitive Assessment (MoCA) score \<18
  • Having a Beck Depression Inventory score \>31;
  • Having absolute contraindications to exercise;
  • Having severe osteoporosis;
  • Participating in an exercise or drug trial during the period of the study;
  • Exceeding the physical activity levels recommended for the general population (≥150 minutes/week of moderate-intensity or ≥75 minutes/week of vigorous-intensity cardiovascular activity) and/or strengthening activities...

The study team makes the final eligibility decision.

Where it is enrolling

  • Laval, Quebec, Canada
  • Montreal, Quebec, Canada

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 40 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Laval, Quebec, Canada; Montreal, Quebec, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.